Released Mar 31, 2026, after the close
10-K filed Mar 31, 2026, 90 days after period end · 0001493152-26-014117
Q4 2025 · 10-K
derived · Computed from the longer spans the company filed.
Revenue$2.06M$2.06M derived+2.2% vs Q4 2024−12.8% vs Q3 2025
Net Income-$1.09M-$1.09M derivedN/M vs Q4 2024N/M vs Q3 2025
EPS, diluted—Not derived. Share counts vary by quarter.
Gross Profitderived$1,501,666−0.6%
Operating Incomederived-$1,079,662N/M
Operating Cash Flowderived-$226,129N/M
Free Cash Flowderived-$229,245N/M
Margins · derived
Gross margin73.0%−2.1 pt vs Q4 2024
Operating margin-52.5%+49.0 pt vs Q4 2024
Net margin-53.0%+48.1 pt vs Q4 2024
What the release said
No earnings release is on file for this quarter. Its figures came with the 10-K.
Same quarter
| Metric | Q4 2025dderived from reported figures | Q4 2024dderived from reported figures | Q4 2023dderived from reported figures | Q4 2022dderived from reported figures |
|---|---|---|---|---|
| Revenue | $2.06M | $2.01M | $2.26M | $2.24M |
| Net Income | -$1.09M | -$2.04M | -$1.94M | -$1.97M |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Milestone Scientific Inc. · CIK 855683 · Engraved from SEC EDGAR